Nutropin AQ
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Nutropin AQ, covering 2008-06-09 to 2018-11-15. Get the full timeline:
Most recent: Clinical Trial Update: A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency [Phase 4]